Orphenadrine Citrate
NDC 67296-1077, Orphenadrine Citrate, tablet, extended release, from RedPharm Drug.
- Product NDC
- 67296-1077
- Status
- Listed
- Labeler
- RedPharm Drug
- Dosage form
- TABLET, EXTENDED RELEASE
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA040327
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/67296-1077 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- ORPHENADRINE CITRATE100 mg/1
Pharmacologic classes
Centrally-mediated Muscle Relaxation [PE]; Muscle Relaxant [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 67296-1077-1 | 67296107701 | 10 TABLET, EXTENDED RELEASE in 1 BOTTLE (67296-1077-1) |
Linked data
RxNorm, label and prices
Related lookups
FDA label sections
GET /v1/drugs/labels/1cff761d-e594-a9e6-e063-6394a90a1fd5
Use it
Look up 67296-1077 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/67296-1077 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 67296-1077. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.